The blend is disclosed by weight, at 36 mg total, with no CFU (colony-forming unit) count and no live-versus-pasteurized status stated for Akkermansia muciniphila specifically - a detail that matters, since the human research on this strain (a randomized trial in Nature Medicine ) used a pasteurized form dosed by cell count, not by weight
That said, the SELECT trial suggests the benefits of starting GLP-1 RAs begin early, even at introductory doses
Emerging evidence indicates GLP-1RA therapies not only influence overall appetite and satiety but also fundamentally alter food preference
GLP-1 medications have the potential to do something similarly profound by helping address obesity, which is one of the leading causes of heart disease, diabetes, hypertension, sleep apnea, joint disease, and countless other chronic health problems